Skip to content
★ Sign in to follow
Tatva Chintan Pharma Chem Limited logo

Tatva Chintan Pharma Chem Limited Stock: price and insider trades · India

IN·Mcap ₹40BHealth Care

Tatva Chintan Pharma Chem Limited: what insiders have been doing

Every trade that managers of Tatva Chintan Pharma Chem Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. 2 insiders have disclosed 2 filings since 8 November 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

With 2 filings in twelve months, the company is quieter than the median of 4 filings across the 1,986 companies we follow on the same exchange. Since 2023, the database holds no purchases and 5 sales by insiders of the company.

There has been no open-market purchase by an insider of Tatva Chintan Pharma Chem Limited for at least a year.

Elsewhere in the same sector, our signals recently picked up insider purchases at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.

Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€13M
5 ops. · all time

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 17,129 of 26,911 companies
42.8
score / 100
Value
24
Quality
62
FCF yld-1.8%
Earn yld0.9%
EV/EBITDA47.4x
ROE5.5%
Gross mgn53%
Net mgn8.4%
Debt/EBITDA1.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹1,709.60
Analyst consensus
4 analysts
2.75/5
₹835.00Target ₹1,442.50(-16%)₹1,955.00
Income statement
Revenue₹5.1B
Gross profit₹2.8B56% margin
EBITDA₹967.1M19% margin
Net income₹420.5M9.2% margin
Valuation
PER (trailing)77.7x
PER (forward)41.8x
P/Book5.1x
Beta0.31
Balance sheet & cash
Market cap₹40B
Total debt₹1.2B
Free Cash Flow-₹822.9M
Debt / Equity15%
Profitability & ownership
ROE5.5%
ROA3.8%
% insiders74.2%
% institutions5.8%
Last declaration on 9 February 2026
Declarations7 total
  • ●
    Related company / holdingExecutives
    0SEBI
    715,345 sharesEquity SharesSEBI:324435d31711a20d3996b4df6207556e03154713
  • ●
    PromotersExecutives
    0SEBI
    715,345 sharesEquity SharesSEBI:4fe8bdf98339ddffd3a09a4920eca5e62da06f1d
  • ▼
    Executives
    383M INR28SEBI
    233,766 shares@ ₹1,639.6044100.0% of flowEquity SharesSEBI:c376c5d5912e7714336a00da177d2ee4134b9e42
  • ▼
    Executives
    385M INR28SEBI
    233,767 shares@ ₹1,647.8304100.0% of flowEquity SharesSEBI:5f7863390eec3af2dd73b86e49489da97c902a76
  • ▼
    Related company / holdingExecutives
    339M INR28SEBI
    206,366 shares@ ₹1,642.1154100.0% of flowEquity SharesSEBI:4112f5fb10c41fc77b5348414feae9b561de3dcd
  • ▼
    Executives
    12M INR28SEBI
    7,190 shares@ ₹1,641.2083100.0% of flowEquity SharesSEBI:ad0b603d1af780f3f941615e74042d8abe968874
  • ▼
    Executives
    34M INR28SEBI
    20,211 shares@ ₹1,658.9772100.0% of flowEquity SharesSEBI:fe75ae56c8e983a215ed8bf101a8e86e1b7d210b

7 of 7 declarations

About Tatva Chintan Pharma Chem Limited

Tatva Chintan Pharma Chem Limited is a company specializing in the manufacture of chemical products for the pharmaceutical industry. It is listed on the XBOM market.